Drugs A-Z Is my price fair? Price changes Drug shortages Recalls Medicare prices Upcoming generics What people paid Guides Share what you paid
Theme

Generic drug

Fluvoxamine price, strengths & recalls

Pharmacies pay $7.45 for 30 tablets of Fluvoxamine 100 mg tablet this week, and from $4.58 to $109.89 across its 5 priced strengths and forms. 17 manufacturers make it. Its official label last changed on January 30, 2026.

Generic
Pharmacies pay$7.45for 30 tablets of 100 mg tablet+1.4% in 4 weeks
Fair cash price
$19.07
Strengths
5
Makers
17
Updated
Nov 11

Fluvoxamine price by strength

What pharmacies pay for each strength and form this week (Nov 11, 2026), for 30 tablets. Choose one for its fair price, 52-week chart and makers.

Strength and formPer unitPharmacies pay4 weeks52 weeks
100 mg (24 hr) extended-release capsule$3.66$109.89 / 30 capsules-10.2%-24.6%
150 mg (24 hr) extended-release capsule$3.52$105.59 / 30 capsules-11.4%-28.6%
25 mg tablet$0.1525$4.58 / 30 tablets+0.8%-26.9%
50 mg tablet$0.1949$5.85 / 30 tablets-0.2%-18.4%
100 mg tablet$0.2482$7.45 / 30 tablets+1.4%-6.9%

The lowest cost per tablet is 25 mg tablet at $0.1525. Strengths aren't interchangeable - ask your pharmacist or prescriber before changing.

Supply status: shortages & recalls

No shortage reportedChecked Nov 16, 2026
No ongoing recallsNone on record

What did you pay for fluvoxamine? Help the next person.

Every price shared helps the next person know what's fair - and shows which pharmacies charge the least. Anonymous, 30 seconds.

How were you treated? optional

Free, anonymous, no sign-up. Please don't include personal or health details. Community rules.

Official label & what changed

Last changedJanuary 30, 2026
Version104 of 5
EffectiveJan 29, 2026
Read the label

These highlights do not include all the information needed to use FLUVOXAMINE MALEATE TABLETS safely and effectively. See full prescribing information for FLUVOXAMINE MALEATE TABLETS. FLUVOXAMINE MALEATE tablets, for oral use Initial U.S. Approval: 1994

This drug has a boxed warning

WARNING: SUICIDALITY AND ANTIDEPRESSANT DRUGS

Antidepressants increased the risk compared to placebo of suicidal thinking and behavior (suicidality) in children, adolescents, and young adults in short-term studies of major depressive disorder (MDD) and other psychiatric disorders. Anyone considering the use of fluvoxamine maleate tablets or any other antidepressant in a child, adolescent, or young adult must balance this risk with the clinical need. Short-term studies did not show an increase in the risk of suicidality with antidepressants compared to placebo in adults beyond age 24; there was a reduction in risk with antidepressants compared to placebo in adults aged 65 and older. Depression and certain other psychiatric disorders are themselves associated with increases in the risk of suicide. Patients of all ages who are started on antidepressant therapy should be monitored appropriately and observed closely for clinical worsening, suicidality, or unusual changes in behavior. Families and caregivers should be advised of the need for close observation and communication with the prescriber. Fluvoxamine maleate tablets are not approved for use in pediatric patients except for patients with obsessive compulsive disorder (OCD) [see Warnings and Precautions (5.1)].

WARNING: SUICIDALITY AND ANTIDEPRESSANTS

See full prescribing information for complete boxed warning.

Increased risk of suicidal thinking and behavior in children, adolescents, and young adults taking antidepressants for major depressive disorder and other psychiatric disorders. Fluvoxamine maleate tablets are not approved for use in pediatric patients except those with obsessive compulsive disorder (5.1).

Recent major changes (as listed on the label)

Warnings and Precautions (5.2, 5.10) 8/2023

We check this label every day. When it changes, the sections that changed appear here, old text beside new.

We show the official text and what changed; we don't interpret it. Ask your pharmacist or prescriber what a change means for you.

Approval, patents & generics

Application
NDA021519 · Ani Pharms
First approved
December 20, 2007 (19 years ago)
Latest approved change
August 18, 2023
Approved label
PDF, Aug 22, 2023
Generic makers
10 approved generic applications on the market

Fluvoxamine questions

How much does fluvoxamine cost without insurance?

Pharmacies pay about $7.45 for 30 tablets of fluvoxamine 100 mg tablet ($0.2482 per tablet). A fair cash price - that cost plus a 15% margin and a typical dispensing fee - is about $19.07. If you're quoted much more, check your quote and ask for the pharmacy's cash price.

Is fluvoxamine in shortage?

No shortage is reported for fluvoxamine right now. We check the national shortage list every day.

Has fluvoxamine been recalled?

No recalls are on record for fluvoxamine.

When did the fluvoxamine label last change?

The official label was last updated on January 30, 2026 (version 104). See what changed.

Talk about fluvoxamine

Be kind and stay on topic. No personal health details, links or selling. This is not medical advice.

No comments yet. Questions, tips, what worked for you - start the conversation.

Help the next person

Know what your pharmacy pays.

Every price you share shows someone else what's fair - and which pharmacies charge the least. It takes 30 seconds and it's anonymous.